Current Therapeutic Apheresis Technologies for Inflammatory Bowel Disease

Wiley - Tập 2 Số 2 - Trang 105-108 - 1998
Ken Yatnaji1, Ken Fukunaga1, Shingo Yamane1, Akinori Sueoka1, Yukihiko Nosé1
1*Department of Surgery, Baylor College of Medicine, Houston, Texas, U.S.A.

Tóm tắt

Abstract: A large number of physicians have indicated that patients with inflammatory bowel diseases (IBD) such as ulcerative colitis (UC) and Crohn's disease (CD) respond to current apheresis technology treatment. However, the mechanism of the apheresis procedure is undefined for patients with IBD. IBD appears to be caused by a complex of interactions from the genes, environment, and the immune system; therefore, the immune system plays a crucial role in the inflammatory responses. In this process, lots of interactions occur simultaneously, and they cross relate with each other. This review paper briefly discusses the etiology and pathogenesis of IBD and attempts to elucidate the mechanism that occurs after apheresis treatment.

Từ khóa


Tài liệu tham khảo

10.1056/NEJM197309062891001

10.1016/0140-6736(93)92818-E

10.1097/00004836-199304000-00010

Bicks RO, 1985, The treatment of severe chronically active Crohn's disease by T‐8 (suppresser cell) lymphapheresis, Gastroenterology, 88, A13257

Sawada K, 1995, Leukocytapheresis therapy with leukocyte removal filter for inflammatory bowel disease, J Gastroenterol, 30, 124, 10.1007/BF02347507

Rembacken BJ, 1996, Granulocytapheresis for inflammatory bowel disease, Jpn J Apheresis, 15, S37

Kawamura A, 1995, Efficacy of the cryofiltration for ulcerative colitis, Jpn J Apheresis, 14, 539

10.2177/jsci.13.268

Kasukawa R, 1994, Extracorporeal granulocyte adsorption treatment of patients with rheumatoid arthritis using a cellulose acetate beads (G‐l column), Jpn J Inflam, 14, 239

Nose Y, 1981, Therapeutic plasmapheresis (II), 15

Sanderson IR, 1993, Differential regulation of B7 mRNA in enterocytes and lymphoid cells, Immunology, 79, 434

10.1016/0167-5699(89)90085-6

10.1016/S0016-5085(84)80015-3

Wengrower D, 1987, Pathogenesis of ulcerative colitis (UC): Enhanced colonic formation of inositol phosphates (IP) and platelet activating factor (PAF), Gastroenterology, 92, 1691

10.1084/jem.169.5.1779

10.1016/0167-5699(91)90050-4

Jutila MA, 1989, Function and regulation of the neutrophil MEL‐14 antigen in vivo: comparison with LFA‐1 and MAC‐1, J Immunol, 143, 3318, 10.4049/jimmunol.143.10.3318

Kasiwagi N, 1994, Effect of extracorporeal granulocytapheresis (G‐l) on antigen‐induced arthritis in rabbits, Jpn J Inflam, 14, 313

McKenzie SB, 1988, Textbook of hematology.

Bogg DR, 1983, White cell manual

10.1016/0016-5085(94)90159-7

Tsuda H, 1995, Leukocytapheresis in rheumatoid arthritis. A comparative study with double filtration plasmapheresis, Jpn J Apheresis, 14, 244

Thông tin
Thông tin xuất bản

Wiley

Tập 2 Số 2

105-108

Thông tin tác giả